Aurobindo USA
在场
是其中之一......
Aurobindo 是一家在股票代码 AUROPHARMA (IN) 下上市的公司。
Aurobindo 在 3 个国家有直接业务。
他们在：
高管
查看带有其 9 名主要高管的组织结构图
Aurobindo USA 搜索最多的简介
- Swami Iyer, Chief Executive Officer
- Ramprasad Reddy, Executive Chairman of the Board
- Jamie Downey, Senior Director, Distribution
高管在Aurobindo变化
- K. Ragunathan, Independent Director & Non-Executive Chairman, 将于 20243月31 退休 (新闻发布的2024三月29号).
创建提醒
跟踪 Aurobindo USA 的高管变动
药店
Aurobindo 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Aurobindo USA 的最新新闻稿
- Andhra Port Stake Case: LOC Against YSRCP’s Vijayasai Reddy, MP Alleges ‘Ulterior Motive’
- PressReader.com - Digital Newspaper & Magazine Subscriptions
- Market Commentary
- Stock Radar: Zomato, Alembic Pharma, RITES, Akzo Nobel, Rail Vikas Nigam, Cochin Shipyard, CESC, HG Infra in focus on Monday
- Lisinopril Market Sees Growth Amid Rising Incidences of Hypertension and Cardiovascular Diseases
- Antispasmodics Drug Market Analysis: Segments, Drivers, Distribution Channels, and Growth Factors Forecast to 2024-2031 - Sanofi, Teva Pharmaceuticals, Aurobindo Pharma.
- Cystinuria Treatment Market to Exhibit a Remarkable CAGR of 6% by 2028, Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook
- Market Commentary
- Antiviral Therapy Market Analysis 2024: Size, Share & Growth Report | CAGR 2.4%
- Respiratory Drugs Market is Expected to Soar in the Upcoming Years |Abbott, AbbVie, GlaxoSmithKline
- View more press releases Close
关于 Aurobindo USA 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Swami Iyer 
